Pharmacokinetics of beclomethasone dipropionate in an hydrofluoroalkane- 134a propellent system in Japanese children with bronchial asthma

Allergology International

Volumn 55, Issue 3, 2006, Pages 317-320

  Teramoto, Takahide ^a   Fukao, Toshiyuki ^a   Tomita, Yoshiko ^b   Terauchi, Yoshiaki ^b   Hosoi, Kaori ^a   Matsui, Eiko ^a   Aoki, Minako ^a   Kondo, Naomi ^a   Mikawa, Haruki ^c  

^a GIFU UNIVERSITY   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^c Kansai Denryoku Hospital   (Japan)

Author keywords

Beclomethasone dipropionate; Children with bronchial asthma; Hydrofluoroalkane 134a; Japanese; Pharmacokinetics

Indexed keywords

BECLOMETASONE DIPROPIONATE; DRUG METABOLITE; NORFLURANE; PROPELLANT;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 33748920664     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.55.317     Document Type: Article

References (6)

1. Alexander DJ, Libretto SE. An overview of the toxicology of HFA-134a (1, 1, 1, 2-tetrafluoroethane). Hum. Exp. Toxicol. 1995;14:715-720.
2. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur. Respir. J. 1998;12:1346-1353.
3. Gross G, Thompson P, Chervinsky P, Vanden Burgt J, Study Group. Hydrofluoroalkane-134a heclomethasone dipropionate, 400 μg, is as effective as chlorofluorocarbon beclomethazone dipropionate, 800 μg, for the treatment of moderate asthma. Chest 1999;115:343-351.
4. Harrison LI, Kurup S, Chen LZ et al. Pharmacokinetics of beclomethasone dipropionate (BDP) and metabolites from CFC-free BDP Autohaler in asthmatic children. J. Allergy Clin. Immunol. 1999;103:8128-5129.
5. Harrison LI, Kurup S, Chen LZ, Ekholm BP, Wighton TG, Shapiro GG. Pharmacokinetic comparison of beclomethasone dipropionate extrafine aerosol from two inhaler devices in children with asthma. Eur. J. Clin. Pharmacol. 2002;58:191-195.
6. Senta T, Harrison L, Kurup S et al. Comparative absorption study of HFA-134a beclomethasone dipropionate delivered from a press-and-breathe metered dose inhaler and AutohalerTM inhalation device in a pediatric population with reversible obstructive airway disease. Final Report. Report Number: 1242-BRON. 3M Pharmaceuticals (USA), 1997.